Context: Both Helicobacter pylori and type 2 diabetes mellitus are possible risk factors for colon adenoma.
that infection with H. pylori confers a 1.3-to 2.26-fold increased risk of adenoma (3, 4) . However, other studies have shown no association. Those of Liou et al. (5) and Machida-Montani et al. (6) did not demonstrate a significant increase in risk of colon adenoma conferred by H. pylori infection. Discrepancies have also been seen in the results of meta-analyses, with some demonstrating a positive association between H. pylori infection and colon adenoma (7, 8) , whereas another, based on an East Asian population, showed no statistical association between H. pylori infection and risk of colorectal neoplasm (9) . These inconsistent results challenge the hypothesis of an association between H. pylori infection and colon adenoma. The pathogenic mechanisms responsible for a putative association remain unclear, although some have suggested possible confounding by a third factor (10) .
Diabetes mellitus type 2 is also considered a risk factor for colon adenoma and carcinoma. Several case-control studies and meta-analyses reported that subjects with diabetes had an odds ratio (OR) of 1.45 for colon adenoma (11) and a relative risk of 1.38 for colorectal adenocarcinoma (12) . Tseng et al. (13) also demonstrated that the prevalence of colonic neoplasms was higher in diabetic subjects (26.6 vs 16.5%, P , 0.001). Unlike the possible association between H. pylori infection and colorectal neoplasm, the mechanism by which diabetes might increase colorectal neoplasm has been studied more extensively. One proposed mechanism is that hyperinsulinemia resulting from insulin resistance may directly promote carcinogenesis by stimulating colonic cell growth (14) . The hyperinsulinemia associated with diabetes is thought to lead to carcinogenesis through increased levels of insulinlike growth factor 1 (IGF-1), which increases cell proliferation and inhibits apoptosis, thus promoting tumor growth (15) . Diabetes is one of the most common metabolic disorders in the world, with a rapid increase in prevalence in the last decades (16) . If diabetes indeed increases the risk of colon adenoma, the prevalence of those neoplasms may also be expected to increase.
Past studies of colorectal adenoma risk factors have looked at H. pylori infection or diabetes alone. A possible interaction between the two to increase adenoma risk has not been examined. Our study aimed to investigate the relationship between H. pylori infection and hyperglycemia, assessing any possible synergistic effect they might have on the risk of colorectal adenoma.
Materials and Methods

Patients
This was a retrospective, cross-sectional study analyzing the data of 3943 subjects who had had a routine health examination at MacKay Memorial Hospital, Taipei, Taiwan, between July 2006 and June 2015. Asymptomatic patients who underwent bidirectional endoscopy [complete colonoscopy and esophagogastroduodenoscopy (EGD)] on the same day were considered for analysis. Inclusion criteria included patients aged .40 years who had screening colonoscopy and EGD along with a urease test to detect H. pylori infection. We excluded patients who had proven colorectal carcinoma; had a high risk of developing colorectal carcinoma, including those with inflammatory bowel syndrome, a positive family history of polypoid syndromes, or a prior history of carcinoma; had inadequate bowel preparation for colonoscopy or underwent incomplete colonoscopy; lacked results for an H. pylori urease test on a gastric biopsy specimen or basic blood test data; or were undergoing a repeat EGD and colonoscopy as part of an annual examination. Based on those criteria, 1468 subjects were excluded, leaving a final study population of 2475 (1656 men and 819 women).
Questionnaire
Baseline characteristics (age, height, weight, personal medical history, current medications, family history of first-degree relatives, and smoking) were obtained from a questionnaire completed at the time of the examination.
Clinical data collection
Blood tests for levels of fasting plasma glucose, hemoglobin A1c (HbA1c), total cholesterol, triglycerides, and low-density lipoprotein were obtained on the same day that EGD and colonoscopy were performed. Standard EGD with a gastrofibroscope (GIFQ260; Olympus Optical, Tokyo, Japan) was performed. A specimen was taken from the gastric antrum using biopsy forceps and assessed within 60 minutes for H. pylori with a rapid urease test (CLO, Pronto-Dry; Gastrex Corp., Warsaw, Poland). A color change from yellow to red on the test agar indicates the presence of H. pylori, which contains intracytoplasmic urease. Subjects were stratified by HbA1c level according to the latest American Diabetic Association criteria (17) to examine the relationship between hyperglycemia and colon polyps. Four HbA1c levels were defined as #5.6%, 5.7% to #6.4%, 6.5% to ,7%, or $7%. This classification was based on the diagnosis and classification of diabetes mellitus and intended to highlight the dose-dependent effect of hyperglycemia on colon adenoma formation (17) .
Colonoscopy was performed from the anus to the ileocecal area by experienced gastroenterologists using a CF Q260AL colonoscope (Olympus Optical). Large (.0.5 cm) polyps were removed with standard polypectomy snares and small (,0.5 cm) polyps with biopsy forceps. For purposes of the study, colonoscopy findings were classified in four subgroups: polyp-free, hyperplastic polyps, nonadvanced adenomatous polyps (tubular adenoma ,1 cm), and advanced adenomatous polyps (tubular adenoma $1 cm, adenoma with .25% villous component, or high-grade dysplasia) (18) . Findings such as juvenile or inflammatory polyps, lipomas, lymphoid aggregates, and chronic nonspecific inflammation were regarded as normal mucosa. The study was approved by the MacKay Memorial Hospital Institutional Review Board (12MMHIS163).
Statistical analysis
The following variables were recorded for each subject: age, sex, body mass index (BMI), HbA1c, lipid levels, smoking status, family history of colorectal cancer, and H. pylori status. Additionally, the presence, size, and location of colorectal adenomas were recorded. A t test was applied for continuous variables when the data fit a normal Gaussian distribution. We used the t test to compare continuous variables for H. pyloripositive and H. pylori-negative subjects. Data for continuous variables were expressed as mean 6 standard deviation. Categorical variables were tested with the x 2 test and expressed as numbers (percentage). Unadjusted ORs with 95% confidence intervals (CIs) were computed for potential predictors of colorectal polyps and adenomas. Multivariate logistic regression analysis was applied to compute the adjusted OR (95% CI) for predictors of colorectal polyps and adenomas. All variables with a P , 0.2 on univariate analysis were selected for multivariate logistic regression. The final model was developed with a stepwise backward approach. All variables with a P , 0.05 were considered statistically significant and remained in the final model. All analyses were done in SAS version 9.1 (SAS Institute, Inc., Cary, NC).
Results
Demographics of H. pylori-positive and H. pylori-negative subjects
The prevalence of H. pylori infection was 984 in 2475 (39.76%). Table 1 shows the characteristics of H. pylori-positive and H. pylori-negative subjects. The H. pylori-positive group had a significantly higher mean HbA1c and incidence of adenomatous polyps than the H. pylori-negative group (Table 1) . There were no significant differences between the two groups in any of the other variables. Family history of colorectal cancer, smoking history, and use of antiplatelet agents did not differ significantly between the groups.
Univariate analysis and multivariate logistic regression for predictors of colorectal adenoma
On both univariate and multivariate analysis, age .60 years, male sex, BMI .27 kg/m 2 , smoking history, firstdegree relatives with colorectal cancer, H. pylori positivity, and HbA1c $6.5% were significantly associated with a higher frequency of adenoma (Table 2) . Age, sex, and obesity were well-known risk factors for colorectal neoplasm (19, 20) . In Asia, the definition of obesity (stage I) is BMI .27 (21) . The aforementioned factors were independent risk factors for colorectal adenoma. Except for H. pylori and elevated HbA1c, other factors were related to participant physical characteristics. Among subjects who were H. pylori-positive, the percentage who were polypfree decreased significantly with each higher HbA1c level (Supplemental Table 1 ). This difference was not seen in the H. pylori-negative patients. However, in both H. pyloripositive and H. pylori -negative patients, each higher HbA1c category was associated with a higher prevalence of colon adenomas and advanced adenoma, and this trend was more obvious in H. pylori-positive patients (Supplemental Table 1 ).
Effect of hypoglycemic agents and HbA1c level on colon adenoma incidence
Among patients being treated with hypoglycemic agents for diabetes, there was an apparent but nonsignificant difference depending on HbA1c, with a somewhat higher incidence of colon adenoma in those who had an HbA1c .6.5% (Table 3) . However, in those not on hypoglycemic drugs, the incidence of adenoma was significantly higher in those with an HbA1c .6.5% compared with those with a lower value (54.7% vs 26.27%, P , 0.0001).
Colon adenoma formation OR by HbA1c level and H. pylori status
On multivariate logistic regression analysis, a 1% increase in HbA1c was associated with a 42.4% increase in the prevalence of adenoma (OR 1.42; 95% CI, 1.23 to Tables 4 and 5 ). An interaction between H. pylori infection and HbA1c level was shown by the significant increase in colon adenomas as HbA1c levels increased, most prominently in the presence of H. pylori infection (Supplemental Table 2 ).
Discussion
This study demonstrates a synergistic effect of diabetes and H. pylori infection on the risk of colon adenoma. As noted earlier, several studies have shown an association between H. pylori infection and colon adenoma (3, 4) and between diabetes and adenoma (11) (12) (13) (14) . Others have discussed the relationship between H. pylori infection and metabolic disease. A large prospective cohort study showed that H. pylori infection leads to an increased rate of incident diabetes (22) . Hyperglycemia in vitro can also promote growth of H. pylori isolates and facilitate bacterial adhesion to gastric epithelial cells (23) . In our study, the HbA1c level was significantly higher in participants with H. pylori infection ( Table 1 ). The prevalence of adenomatous polyps was also higher in the H. pylori-positive group (37.30% vs 27.29%, P , 0.05), as was also seen in the studies of Sonnenberg and Genta (3) and of Nam et al. (24) . Additional univariate and multivariate logistic regression analysis showed that age, male sex, BMI, smoking history, first-degree relatives with colorectal cancer, H. pylori infection, and HbA1c .6.5% were independent risk factors for colorectal adenoma ( Table 2) . Use of antiplatelet agents did not differ significantly between those with or without adenomas. This result may relate to study design, because it was a retrospective, cross-sectional study, so the long-term effect on the incidence of adenoma of antiplatelet agents could not be demonstrated in our study. Treatment of diabetes with hypoglycemic agents was associated with a decreased the risk of colon adenoma on multivariate logistic regression analysis. Additional analysis of our participants' data showed that in patients with diabetes who maintain an HbA1c ,6.5%, the incidence of colon adenoma was similar to that of those without diabetes. Even with an HbA1c .6.5%, patients taking hypoglycemic agents also had a lower colon adenoma incidence than those with untreated diabetes (Table 3) . Metformin has been shown in several studies to reduce colon adenoma risk, even in patients without diabetes (25, 26) . Algire et al. (27) suggested that metformin may inhibit the proliferation of human colon cancer cells. This is may be why treatment of diabetes could decrease the risk of colon adenoma.
On multivariate logistic regression analysis, the two chronic conditions of H. pylori infection and diabetes were independent risk factors for colon adenoma. Our findings indicate that the two factors together further increased the risk of adenoma. Each higher level of HbA1c was associated with an increased incidence of adenoma, an effect seen in both groups but more obvious in the H. pylori-positive group. For H. pylori-positive patients, the prevalence of colon adenoma increased by 42.4% when HbA1c increased by 1%, compared with only a 15.1% increment in those without H. pylori infection. For H. pylori-negative patients, the OR for colon adenoma was significantly higher at 1.68 (95% CI, 1.05 to 2.70; P = 0.0314) in patients with an HbA1c .7.0%. However, for participants with both an HbA1c .7.0 and H. pylori infection, the OR was 4.79 (95% CI, 2.92 to 7.84; P , 0.0001). This suggests that the combination of HbA1c $7.0% and H. pylori infection had a synergistic effect on the risk of colon adenoma (Tables 4 and 5) .
How H. pylori infection relates to colon adenoma has been investigated (3, 4). Sonnenberg and Genta (3) reported a large-scale study of 156,000 subjects, finding an OR for colon adenoma in H. pylori-positive patients of 1.52 (95% CI, 1.46 to 1.57). Even with this impressive study size, there are some unaddressed issues, and it has been suggested that this association should be interpreted with caution (10) . One of the challenges is to understand a plausible mechanism by which H. pylori infection contributes to colon polyp formation. Thorburn et al. (28) reported that hypergastrinemia may promote colorectal neoplasia in humans, because gastrin is capable of stimulating growth factor-dependent signaling pathways. But another recent report demonstrated that hypergastrinemia did not increase the risk of colonic neoplasms, and there was no difference in basal serum gastrin levels between patients with or without H. pylori infection (29) .
A relationship between the inflammatory pathway and colon neoplasm formation has also been reported. Chiu et al. (30) found that elevated C-reactive protein levels were associated with colon neoplasms. H. pylori is a gram-negative bacterium with an outer membrane that includes a complex lipopolysaccharide. The lipid portion acts as an endotoxin and elicits strong immune responses in humans (31) . Grivennikov et al. (32) studied the role of microbiota in inflammation of the gut. He found that colorectal adenomas in both human and mouse models increased the amounts of interleukin (IL)-23 and IL-17. When the gut mucosa toll-like receptors were stimulated by bacterial products such as lipopolysaccharide, IL-23 increased and acted on downstream cells, including lymphocytes. This effect may activate the inflammatory process, leading to increases in IL-17 and (35) showed that H. pylori infection might play a role in increasing the circulating levels of endotoxins in patients with chronic liver disease. Of course, H. pylori is not alone in the gram-negative gut microbiota, so that other organisms (e.g., Bacteroides spp.) may be responsible for increased plasma endotoxin levels. The interaction between different gut microorganisms is less well understood. However, these studies still support the idea that H. pylori infection may have a role in the pathogenesis of colon adenoma. Endotoxin absorption from the gut into the circulatory system occurs by two mechanisms: chylomicronfacilitated transport and extracellular leakage through tight junctions in the epithelial lining (36) . Gut barrier loss and changes in permeability may be effects of hyperglycemia on gastrointestinal morphology and function. In patients with type 2 diabetes, high-fat and high-calorie diets increase intestinal permeability (37) . Endotoxins could then be transported more quickly from the intestinal lumen toward a target tissue. By a mechanism facilitated by chylomicrons synthesized by the intestinal epithelial cells in response to a high-fat diet, patients with hyperglycemia may be more likely to have endotoxemia (38) . Because patients with type 2 diabetes often have hyperinsulinemia, the consequent increased levels of IGF-1 may promote tumor growth by increasing cell proliferation and inhibiting apoptosis (14) . These findings support our contention that the combination of diabetes and H. pylori infection may have a synergistic effect on the development of colon adenomas.
Our study has several limitations. First, it was a retrospective observational study. It included only patients undergoing bidirectional endoscopy on the same day, meaning that our sample may not be representative of the general population. Second, a cross-sectional study can show only an association between H. pylori infection and diabetes on the risk of colon adenoma. Therefore, additional animal model experiments or human case-control studies are needed to prove a cause-and-effect relationship.
Conclusion
Our study demonstrated the benefit of diabetes control in decreasing the risk of colon adenoma and showed that the combination of H. pylori infection and elevated HbA1c has a synergistic effect on the risk of colon adenoma. Given the increasing prevalence of diabetes, an increase in the incidence of colon adenoma can be expected. It raises the question of whether eradicating H. pylori infection and controlling diabetes might reduce the prevalence of colorectal adenoma.
